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Abstract
Background: Cellular function and diversity are orchestrated by complex interactions of fundamental biomolecules
including DNA, RNA and proteins. Technological advances in genomics, epigenomics, transcriptomics and proteomics
have enabled massively parallel and unbiased measurements. Such high-throughput technologies have been extensively
used to carry out broad, unbiased studies, particularly in the context of human diseases. Nevertheless, a unified analysis
of the genome, epigenome, transcriptome and proteome of a single human cell type to obtain a coherent view
of the complex interplay between various biomolecules has not yet been undertaken. Here, we report the first
multi-omic analysis of human primary naïve CD4+ T cells isolated from a single individual.
Results: Integrating multi-omics datasets allowed us to investigate genome-wide methylation and its effect on
mRNA/protein expression patterns, extent of RNA editing under normal physiological conditions and allele
specific expression in naïve CD4+ T cells. In addition, we carried out a multi-omic comparative analysis of naïve
with primary resting memory CD4+ T cells to identify molecular changes underlying T cell differentiation. This
analysis provided mechanistic insights into how several molecules involved in T cell receptor signaling are
regulated at the DNA, RNA and protein levels. Phosphoproteomics revealed downstream signaling events that
regulate these two cellular states. Availability of multi-omics data from an identical genetic background also
allowed us to employ novel proteogenomics approaches to identify individual-specific variants and putative
novel protein coding regions in the human genome.
Conclusions: We utilized multiple high-throughput technologies to derive a comprehensive profile of two primary
human cell types, naïve CD4+ T cells and memory CD4+ T cells, from a single donor. Through vertical as well as
horizontal integration of whole genome sequencing, methylation arrays, RNA-Seq, miRNA-Seq, proteomics, and
phosphoproteomics, we derived an integrated and comparative map of these two closely related immune cells and
identified potential molecular effectors of immune cell differentiation following antigen encounter.
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Background
The advent of next generation sequencing technologies
has enabled broad unbiased surveys of genomic, epige-
nomic and transcriptomic landscapes in unprecedented
detail. The last several years have witnessed tremendous
application of these novel high-throughput genomic
methods in advancing biomedical sciences. Similarly, ad-
vances in mass spectrometry-based approaches have rev-
olutionized biological research by allowing systems level
analysis of proteins and post-translational modifications
[1]. A recent study by Chen et al. was a first attempt to
integrate these high-throughput methods into an inte-
grative personal omics profile of a single individual [2].
This study combined genomic, transcriptomic, prote-
omic, metabolomic and autoantibody profiles and dem-
onstrated the ability to predict medical risks. However,
the data was generated on peripheral blood mono-
nuclear cells, which is a mixed population of different
cell types including lymphocytes, monocytes and macro-
phages. This cellular heterogeneity makes it difficult to
gain mechanistic insights into how genome and epige-
nome level alterations regulate RNA and protein expres-
sion. In addition, the ability to interrogate post-
transcriptional and post-translational modifications on
these biomolecules and correlate changes to their gen-
omic and epigenomic states is complicated by the het-
erogeneity of cell types.
In order to overcome these limitations, we carried out
a multi-omic study on a purified population of naïve
CD4+ T cells from a single individual. Naïve CD4+ T
cells are a developmentally synchronized and relatively
homogeneous cell population [3–6]. Here we describe
the generation of a comprehensive landscape of genome,
epigenome, transcriptome and proteome of naïve CD4+
T cells (Fig. 1, Additional file 1: Figure S1). This dataset
allowed us to correlate mRNA, miRNA and protein
expression patterns of naïve CD4+ T cells with their
genomic and epigenomic states. Integration of this
multi-omics data also allowed us to interrogate post-
transcriptional modifications such as RNA editing in a
more precise and detailed manner as well as to iden-
tify protein-coding regions that are absent in public
databases.
We also carried out a multi-omic comparison of naïve
CD4+ T cells and antigen experienced resting memory T
cells, which provided mechanistic insights into the epi-
genetic, transcriptomic and proteomic events that are
characteristic of two closely related T cell states. Add-
itional phosphoproteomic analysis also allowed us to de-
termine underlying signaling mechanisms that operate
in these two cellular states of T cells.
Results and discussion
To guide our analysis of naïve CD4+ T cells, we took the
following approach. First, we began by characterizing in-
dividual omes. This was followed by various pairwise in-
tersections of our data to quantitatively and qualitatively
assess relationships between the different data types.
This multi-omic integration also allowed us to gain in-
sights into RNA editing, allele-specific expression and
to customize our proteomic search strategies. Lastly,
we performed a comparative analysis of the methylome,
transcriptome, proteome, and phosphoproteome of
naïve and memory CD4+ T cells to explore the cellular
mechanisms underlying the T cell immunological re-
sponse. This entailed both a pairwise approach as well
as an integrative, pathway level analysis to identify mo-
lecular changes following antigen experience of naïve
CD4+ T cells.
Fig. 1 Summary of large-scale omics datasets acquired and the corresponding technologies that were used in this study
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Genomic variations and their potential impact on protein
coding regions
Our analysis revealed ~3.3 × 106 SNPs, 1.75 × 105 inser-
tions and 1.9 × 105 deletions across the genome (Additional
file 2: Figure S2A). Nearly 16,000 SNPs, 130 insertions and
109 deletions were found within protein-coding genes.
These sequence alterations led to generation of 107
premature stop codons, 14 nonstop mutations, and 109
frameshifts. Most SNPs within protein-coding regions
were synonymous or introduced conservative amino
acid changes (Additional file 2: Figure S2B). There were
7,271 non-synonymous changes that predominantly af-
fected protein families associated with extracellular en-
vironment including G-protein coupled receptors,
immunoglobulins, cell surface/membrane proteins and
ion channels (Additional file 2: Figure S2C). This is in
agreement with recent observations that potential loss-
of-function mutations are quite common in healthy in-
dividuals, particularly in gene families that have several
paralogs [7]. There are also anecdotal observations that
variants in surface or secreted molecules may account
for the vast heterogeneity of immune responses and nu-
trient absorption present in a given population [8–10].
Among genes with non-synonymous changes, MAP2K3
contained a homozygous variant that introduced a prema-
ture stop codon resulting in truncation of most of the
MAP2K3 kinase domain. This is particularly interesting
considering that MAP2K3 is involved in the activation of
p38-MAPK, which in turn has been shown to promote
transcription of multiple genes involved in cell cycle regu-
lation and apoptosis such as p53 and MYC [11, 12]. An-
other homozygous variant leading to a potential loss of
protein function was an insertion within phospholipase
PLCD3 that introduced a frameshift. This mutation resulted
in the loss of PLC and C2 domains, which are responsible
for hydrolysis of phosphatidylinositol 4, 5-bisphosphate to
diacylglycerol and inositol 1,4,5-trisphosphate (IP3). These
findings are surprising given that the cells were obtained
from a healthy voluntary donor and likely reflect that
the affected pathways may have compensatory mecha-
nisms. It is important to note that these two loss-of-
function mutations have been recently reported to be
frequent in the genomes of healthy individuals from
multiple populations [7].
Transcriptome landscape of naïve CD4+ T cells
We sequenced the transcriptome of naïve CD4+ T cells
using paired-end RNA sequencing. The abundance of
assembled transcripts was estimated using FPKM (Frag-
ments Per Kilobase of exon per Million fragments
mapped) and showed a bimodal distribution (Additional
file 3: Figure S3). A Gaussian mixture model was applied
to model these two distributions. Analysis of transcripts
under each peak revealed that the low FPKM peak con-
tained transcripts with few supporting reads that we
considered noise. With an FPKM cutoff of two standard
deviations from the mean of the left peak (0.860), we
found >13,000 transcribed genes represented by ~24,000
transcripts (Fig. 2a; Additional file 4: Table S1). As ex-
pected, we detected expression of several cytokine recep-
tors associated with well-defined effector helper CD4+ T
cell populations such as Th1 (IL2RA, IL2RB, IL2RG,
IFNGR1, and IL12RB1), Th2 (IL4R and IL10RB), and
Th17 (IL17RA, IL17RC, IL21R). In general, cytokines,
cytokine receptors, major histocompatibility complex,
and genes encoding cell surface proteins (e.g., CD4) were
expressed at above average levels. As expected, the most
abundantly expressed genes included those that code for
ribosomal proteins and ribosomal RNA. We identified
an additional >2,000 novel transcripts and >6000 novel
spliced isoforms absent in our reference annotation (ref-
erence annotation composition provided in methods)
(Additional file 5: Table S2). We validated the expression
of a set of randomly chosen novel transcripts by RT-
Fig. 2 Transcriptome of naïve CD4+ T cells. a Pie chart representing the number of diverse classes of transcripts identified in naïve CD4+ T cells.
b Agarose gel depicting PCR amplified products from RNA isolated from various hematopoietic cell types. Labels at the top show surface markers
based on which the cells were purified and labels on the side show cufflinks identifier for each transcript
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PCR amplification and sequencing in a panel of primary
immune cells including naïve CD4+ T cells. Two of the
seven transcripts showed ubiquitous expression across
all the tested primary immune cells while others were
relatively specific to T cells (Fig. 2b).
We next examined the miRNA profile of naïve CD4+ T
cells. miRNA-Seq generated 7.6 million usable reads that
were aligned using miRdeep2, identifying 629 known
miRNAs as well as 15 putative novel miRNAs (Additional
file 6: Table S3). These putative novel miRNAs were iden-
tified based on the presence of characteristic features of
miRNAs including hairpin formation, sustainable stem-
loop structure as well as mature and star sequences as
shown in Additional file 7: Figure S4. Over 99.9 % of the
reads correspond to 283 miRNAs, suggesting that this
forms the primary pool of miRNAs expressed in naïve
CD4+ T cells. Using a previously published method, we
established that an FPKM of ~73 corresponded to a
single miRNA copy per cell, which equates to ~50 % of
miRNAs identified being present in at least one copy
per cell and ~13 % with at least 100 copies [13].
Proteomic profile of naïve CD4+ T cells
We carried out an in-depth proteomic analysis of naïve
CD4+ T cells using multi-dimensional separation methods
as well as subcellular fractionation of the nucleus, mem-
brane, and cytosol [1, 13]. In total, proteins encoded by
7,449 genes were identified (Additional file 8: Table S4).
To determine the abundance of proteins expressed in
naïve CD4+ T cells, we employed intensity-based absolute
quantitation (iBAQ) [14] (Fig. 3a). In agreement with
transcriptome data, cell surface proteins and constituents
of the histocompatibility complex were found to be abun-
dantly expressed. As expected, we identified several cyto-
kine receptors, including IL2RG (CD132), the common
gamma chain shared by multiple cytokines receptors
(IL2, IL4, IL9, IL15, and IL21) that plays a vital role in
T cell signaling [15]. Interestingly, we detected CRLF2,
which partners with IL7R and serves as a receptor for
TSLP, a major cytokine released by epithelial cells [16–
18]. The current paradigm of TSLP signaling states that
TSLP influences CD4 T cell function, homeostasis, and
pathogenic effects through modulation of dendritic
cells. However, given that TSLP is one of the earliest
cytokines secreted during inflammation, and CRLF2
and IL7R are co-expressed in naïve CD4+ T cells, these
results suggest a likely scenario in which naïve CD4+ T
cells could directly sense inflammation locally via the
TSLP signaling complex.
We identified 162 proteins annotated as open reading
frames (ORFs) in public databases (Additional file 9:
Table S5). Some of these proteins were abundantly
expressed in naïve CD4+ T cells and have characteristic
domain architecture including signal peptides, trans-
membrane domains and phosphatase domains (Fig. 3b).
Future studies may establish some of these molecules as
additional novel CD antigens, cytokines and chemokines.
Interestingly, we discovered three proteins that have
been removed from RefSeq’s protein database (version
71): NP_003917.1, NP_059120.2, and NP_115949.3 (cor-
responding gene symbols shown in red in Fig. 3a). These
proteins were removed due to insufficient protein evi-
dence, transcript evidence, or both. In all three cases, we
found mRNA as well as protein evidence supporting their
transcription and translation. In the future, such false neg-
atives (i.e., annotations that are suppressed for lack of evi-
dence) can be avoided by integrating transcriptomic and
proteomic evidence from published studies.
Integration of multi-omics datasets
Vertical integration of genome-wide multi-dimensional
datasets from an identical background provided us the
opportunity to explore 1) how genome sequence and as-
sociated epigenetic modifications such as methylation
regulate RNA and protein expression in cells; 2) the ex-
tent of post-transcriptional modifications such as RNA
Fig. 3 Distribution of proteins expressed in naïve CD4+ T cells based on their relative abundance. a Distribution of proteins identified in naïve
CD4+ T cells and their corresponding abundance based on normalized iBAQ (log2) values. Genes shown in red indicate those that have been
removed in NCBI RefSeq 62, but were detected in our proteomics study. b Predicted domain architecture of a subset of RefSeq annotated
hypothetical proteins identified in our study
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editing in cells under normal physiological conditions; 3)
genes that display allele-specific and isoform-specific ex-
pression patterns; and, 4) miRNA expression patterns
and their potential influence on the expression of pro-
tein targets. Because we gathered data spanning from
the genome to the proteome, we could also explore the
possibility of novel protein coding regions in the human
genome.
Allele specific expression pattern and RNA editing
By combining whole genome and transcriptome sequen-
cing data from a purified single cell type, we were able
to investigate allele-specific expression and RNA editing
events. As sequence variants that distinguish two alleles
are necessary to draw inferences on allele specific ex-
pression patterns, we surveyed all genes containing het-
erozygous SNPs in accordance with previous approaches
[19, 20]. The abundance levels of these genes revealed
84 genes in which only one allele showed detectable ex-
pression levels. For genes where both alleles were de-
tected, we defined allele-specific expression as cases
where at least 10 reads were mapped and there was at
least a 5 fold difference in reads mapped between alleles.
Using these criteria, we identified 103 genes where one
allele was predominantly expressed. This included
known imprinted genes such as ATP10A and SNRPN
along with many additional protein-coding genes,
pseudogenes and non-coding RNAs that have not been
previously reported as imprinted (Additional file 10:
Table S6).
RNA editing is a post-transcriptional mechanism by
which the enzymatic deamidation of RNA nucleotides
results in altered codon-anticodon pairing. In next gen-
eration sequencing, these changes are ultimately re-
ported as adenosine to guanine or cytosine to thymine
transitions. These changes can impact biological pro-
cesses ranging from miRNA binding to protein function.
To date, RNA editing has not been studied in a single,
purified primary cell type, although it has been evaluated
in the context of immortalized cell lines and in tissues
[21–23]. To identify sites of RNA editing in naïve CD4+
T cells, we developed a pipeline, depicted in Fig. 4a (a
more detailed workflow is shown in Additional file 11:
Figure S5). Analysis of aligned RNA-Seq data revealed
9,877 potential sites of RNA editing (referred to as RNA
DNA Differences, or RDDs) of which 93 % corresponded
to a SNP found in whole genome sequencing. RDD con-
taining sequences were then aligned using BLAST or
BLAT, which identified another 3 % of RDDs as align-
ment errors, often involving pseudogenes. Removal of
Fig. 4 Workflow and summary of RNA editing events observed in naïve CD4+ T cells. a The workflow that was used to identify putative sites of
RNA editing in naïve CD4+ T cell transcriptome. The number of putative RNA editing sites is shown on the y-axis and reasons for disqualifying
them are represented on the x-axis. b Matrix showing all the nucleotide substitutions observed in the confirmed RNA editing sites. The numbers
highlighted in red indicate canonical changes (A-to-G and C-to-T). G-to-A and T-to-C are also highlighted as those changes are likely canonical
edits with incorrect strand assignment of RNA-Seq data. Numbers highlighted in green are non-canonical events. c Distribution of RNA editing
sites based on their location within transcripts
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these false positives left 333 potential RNA editing sites.
To validate these sites, targeted enrichment and re-
sequencing of DNA and RNA was performed on 94
sites. 22 sites were found by DNA re-sequencing to be
SNPs not called by our initial WGS. Of the remaining
72 sites validated, 38 were rediscovered as RDDs. For
the remaining 34 sites not rediscovered, the edited base
was not found at appreciable levels in our targeted se-
quencing data (all 34 had either 0, 1, or 2 reads support-
ing the putative RDD), which implies the initial edit may
have been a sequencing error. Sites that were validated
were predominantly comprised of known, canonical edit-
ing sites (A-to-G and C-to-T) (Fig. 4b). To elucidate the
functional impact of validated sites, we determined if
they were found in protein-coding regions or non-
coding regions (i.e., regions considered to be non-coding
or untranslated regions of protein-coding regions). As
shown in Fig. 4c, the majority of edits occurred in non-
coding regions of transcripts with little obvious impact on
protein coding regions, which is consistent with a recent
study [24]. Interestingly, when examining miRNA binding,
we found that 28 miRNA seed sequences were modified
by RNA editing and 25 novel sites were created by edits,
which may indicate a possible role for RNA editing in
miRNA mediated regulation of protein expression.
Proteogenomic analysis by integrating multi-omics data
Availability of high coverage genomic, transcriptomic
and proteomic data allowed us to annotate novel protein
features as well as refine existing annotations [25].
Using our proteogenomics pipeline outlined in
Additional file 12: Figure S6, we searched unmatched
tandem mass spectra against custom peptide/protein
sequence databases that incorporated genomic variants
revealed by whole genome sequencing. In addition, we
built custom protein databases comprised of a 6-frame
translation of human genome build 19 and a 3-frame
translation of our RNA-Seq reference annotation (com-
prised of mRNAs, ncRNAs, lncRNAs, and pseudo-
genes). In our proteome dataset, we identified >10,000
peptides that spanned known exon splice junctions and
identified 17 peptides providing evidence for the coding
potential of 11 novel exons, all of which were identified
from RNA-Seq data as well. An example of a novel iso-
form of FXR1 identified using RNA-Seq as well as
proteomic data is shown in Fig. 5. We also identified 2
potential upstream ORFs based on 2 peptides identified
in untranslated regions of known mRNAs (Additional
file 13: Table S7). To characterize and discover new
translational start sites, we searched for N-terminal
acetylation of proteins. We identified 1,740 N-terminal
acetylated peptides, which confirm existing annotations
of translation start sites for 1,720 gene products. To locate
alternative start sites, a database containing alternate me-
thionine residues immediately upstream or downstream of
known translational start sites was created. From this, 20
alternate N-termini acetylated peptides downstream of
currently annotated protein sequences were identified,
providing experimental support for previously unknown
translation start sites.
Fig. 5 Proteogenomics approach to identify novel protein coding regions. A peptide identified by proteogenomics that mapped to an intronic
region of FXR1 gene. MS/MS spectra of the peptide and read density from RNA-Seq data that supports the new isoform are depicted
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Signal peptides are an integral part of post-translational
translocation of proteins to specific locations within or
outside the cell. Presently, database search-driven algo-
rithms are unable to successfully predict cleavage sites and
identify signal peptides due to difficulties in identifying
unexpected trypsin-cleaved amino acid signal sequences
[26]. To overcome this difficulty, we incorporated tryptic
peptides preceding the cleavage sites based on predicted
signal sequences from SMART [27], SignalP4.0 [28], and
cleavage sites annotated in HPRD [29] into our analysis
pipeline. We identified 35 known and 24 novel signal
peptide cleavage sites (Additional file 14: Table S8). Our
search against a translated pseudogene database identified
3 peptides uniquely mapping to 3 pseudogenes (Additional
file 15: Table S9) suggesting that they are actually putative
novel protein coding genes. These findings illustrate that a
high coverage of the cellular proteome with high resolution
mass spectrometry-derived data allows for a systematic ex-
ploration of the information flow from genome to prote-
ome that can augment genome annotation.
To explore the relationship between protein and tran-
script abundance in naïve CD4+ T cells, we correlated
the iBAQ values of proteins and transcript FPKM values.
A Spearman’s correlation of 0.35 between FPKM and
iBAQ values was found, indicating poor correlation
between transcript and protein abundance (Additional
file 16: Figure S7). To investigate the role of miRNAs in
transcriptional or translational repression of genes
expressed in naïve CD4+ T cells, miRNA levels were
quantified and compared to iBAQ and FPKM values.
From a global perspective, when considering the protein
and transcript abundance of genes that are potential tar-
gets of miRNAs, we found that there was a steady de-
crease in the average protein level of targeted genes with
increasing miRNA read counts (Additional file 17:
Figure S8A). However, at the transcript level, this trend
was not as apparent (Additional file 17: Figure S8B).
DNA methylation patterns and their influence on RNA
and protein expression
Methylation of DNA is one of the most well-known
regulatory mechanisms of gene expression, with in-
creased methylation often corresponding to diminished
transcriptional activity. Here, we assayed genome-wide
methylation patterns using an Illumina 450 K BeadChip
array. The global methylation profile exhibited a bimodal
distribution with 39 % of the assayed sites showing hypo-
methylation (beta value < 0.33) and 52 % showing hyper-
methylation (beta value > 0.66). In promoter regions
(defined as 0–1500 bases upstream of a transcription start
site (TSS)), 69 % of the sites were hypomethylated and
23 % were hypermethylated. In general, the methylation
levels were lower near the TSS and rose through the gene
body and 3′ UTR (Additional file 18: Figure S9).
Methylation levels were also compared with nearby
transcript and protein levels (using FPKM and iBAQ as
measurements for transcripts and proteins, respectively).
This revealed that methylation of promoter regions
showed a weak correlation with lower transcriptional
levels of corresponding genes (Additional file 19: Figures
S10A and S10B). No correlation was observed between
protein abundance and promoter methylation (Additional
file 19: Figure S10C) or methylation of various gene re-
gions (Additional file 19: Figure S10D). We hypothesize
the lack of correlation between methylation and protein
levels found here is due to our global analysis. Because
not all genes are regulated by methylation, and there is a
low correlation between transcript and protein levels, we
believe the true signal of protein levels trending with
methylation levels is obscured. To rectify this, we feel the
correct stratification of data combined with additional ex-
perimental work is needed to detect changes in protein
abundance as a function of methylation.
A multi-omic comparison of naïve CD4+ T cells with
antigen-experienced resting memory CD4+ T cells
Epigenetic regulation of T cell differentiation
Naïve CD4+ T cells differentiate into several lineages of
CD4+ helper T cells after experiencing an antigen - one
lineage being resting memory CD4+ T cells. Resting
memory CD4+ T cells embody the molecular changes
induced by antigen exposure of naïve CD4+ T cells. To
dissect the underlying molecular mechanisms that regu-
late this transition, we carried out a multi-omic compara-
tive analysis of these two closely related cell populations.
To identify promoter methylation dependent regulatory
mechanisms, we intersected methylome and transcrip-
tome data from both cell types and found genes that show
differential methylation patterns that may influence gene
expression. Promoter regions of the kinases LYN and
SGK1 as well as the methyl-transferase/hydrolases MET-
TL7A and DDAH2 were hypomethylated with concurrent
increases in gene expression levels in naïve CD4+ T cells
relative to memory T cells (Additional file 20: Figure S11).
Conversely, promoter regions of CCR6 and chemokine
CCL5, which is essential for migration of CD4+ T cells,
were hypermethylated. Coupled with the decreased ex-
pression levels of these genes in naïve CD4+ T cells, these
results suggest that there are specific molecular changes
in methylation and gene expression involved in the transi-
tion from naïve CD4+ T cells to resting memory T cells
that is consistent with previous observations [30–32].
We next explored the role of non-promoter associated
methylated sites in our dataset. Potential regulatory
DNA methylation sites were identified by comparing
DNA methylation and gene expression patterns in hun-
dreds of tumors from TCGA datasets and selecting sites
with an inverse methylation and gene expression
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correlation (TCGA, https://tcga-data.nci.nih.gov/tcga/) [33,
34]. For each regulatory site identified from the TCGA
dataset, we examined differences in DNA methylation and
gene expression between naïve CD4+ T cells and memory
T cells (Additional file 21: Table S10). This approach
allowed us to enrich for DNA methylation sites, genes
and pathways associated with CD4+ T cell biology
(Additional file 22: Table S11). For example, within the
TCR pathway, many genes known to be critical for T cell
activation were highly methylated at regulatory sites with
concurrent decreases in expression levels in naïve cells as
compared to memory cells. This suggests an epigenetic
regulation of this critical pathway required for T cell
differentiation.
Proteomic and phosphoproteomic differences between
naïve and memory T cells
To investigate signaling differences between naïve CD4+
T cells and memory CD4+ T cells we employed com-
parative proteomic and phosphoproteomic approaches.
Quantitative proteomics was performed using iTRAQ
[35] based methodology, which provides a measure of
protein abundance between samples. In addition, we
enriched phosphopetides from both cell types using a
TiO2-based strategy and quantified their differences
based on ion abundance [27, 36]. As shown in Fig. 6a,
several proteins were found to be differentially expressed
between naïve and resting memory T cells. Interestingly,
many proteins displayed differential phosphorylation
levels between the two cell types without any alteration
in protein abundance. Notable examples of differentially
phosphorylated proteins include two poorly character-
ized kinases, SGK223 and BAZ1B, which showed an in-
verse phosphorylation pattern between the two cell types
(Fig. 6b). SGK223 showed elevated protein as well as
phosphorylation levels in naïve CD4+ T cells, including
two previously unreported sites, Ser508 and Ser805.
Memory cells expressed higher protein levels of kinases
that are known to play critical roles in T cell activation,
including LYN, SYK, BTK and TBK1. Higher expression
Fig. 6 Differential methylation, gene/protein expression and phosphorylation pattern between naïve CD4+ T cells and memory T cells. a
Differential protein expression and phosphorylation pattern between naïve and memory CD4+ T cells. The black data points represent relative
protein expression levels between naïve and memory T cells while the red and blue bars indicate relative phosphorylation levels in naïve and
memory T cells, respectively. b Examples of kinases, phosphatases, proteases, transcription factors and signaling molecules that showed significant
differences in their expression level and/or phosphorylation levels between naïve and memory T cells. Vertical and horizontal ovals represent
proteins and circles represent phosphorylation sites. Higher levels in memory cells are indicated in blue, lower levels are indicated in red while
unchanged abundance is indicated by grey color
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of these kinases in memory cells is consistent with the
notion that antigen exposure of memory cells leads to a
potent and faster immune response by virtue of having
elevated levels of signaling molecules [38]. Our prote-
omic analysis also indicated differential phosphorylation
of well-studied adaptor proteins in T cell signaling. For
instance, caspase recruitment domain-containing protein
11 (CARD11) is a multi-domain scaffolding molecule re-
sponsible for mediating NF-kB activation during T cell
activation [39, 40]. Phosphorylation of Ser552, Ser564,
and Ser657 in CARD11 is known to induce CARD11-
mediated NF-kB activation while phosphorylation of
Ser649 is known to down-regulate NF-kB activation
[41, 42]. Most interesting, however, were proteins that
were not differentially expressed between samples, but
were differentially phosphorylated. BAZ1B, a recently
discovered tyrosine kinase, exhibited similar protein
levels in both cell types but showed elevated phosphor-
ylation levels in memory cells. Six differentially phos-
phorylated sites were identified on BCL10, a key
component of the CARD11-BCL10-MALT1 complex
that regulates NF-kB activation [43, 44]. The novel sites
Ser121, T130, S134, S136, Ser141 and previously known
Ser138 were all highly phosphorylated in memory CD4
+ T cells. Ser138 negatively regulates NF-kB activation
and thus the increased phosphorylation of this site in
naive cells is consistent with antigen inexperience
where NF-kB activation is limited [45].
During T cell activation, proteolytic cleavage by caspase-
3 converts pro-IL16 to IL16, a proinflammatory chemo-
attractant that stimulates cell migration [46, 47]. The IL16
precursor pro-IL16 is a nuclear and cytoplasmic scaffold-
ing protein involved in cell cycle arrest through associ-
ation with a broad range of proteins including HDACs
and ion channels in resting T cells [48]. In our study, pro-
IL16 protein expression levels were comparable between
naïve and memory CD4+ T cells. However, phosphoryl-
ation patterns were different between these two closely re-
lated cells. We have identified 16 phosphorylation sites, 10
of which are novel, in pro-IL16. Interestingly, 6 of the 16
sites were highly phosphorylated in naïve CD4+ T cells
while Thr1058 was highly phosphorylated in memory
cells. These findings parallel the different roles pro-IL16
plays in naïve and memory CD4+ T cells. Through a com-
bined analysis of quantitative proteomic and phosphopro-
teomic data, we were able to probe T cell biology and gain
novel insights into phosphorylation mediated regulation
of these two cell phenotypes. Together, these findings sug-
gest an active role for new kinases and reveal signaling
events that may be crucial in T cell activation.
By integrating data from methylome, transcriptome,
proteome, and phosphoproteome, we obtained a com-
prehensive view of molecular events that regulate naïve
and memory T cells (Fig. 7). To assess the utility of an
integrated pathway, we evaluated several key signaling
molecules in the context of immune function. Given that
both cell populations are in a resting state, LCK, a key
downstream kinase in the TCR pathway, is unchanged
both at the protein and phosphorylation levels. However,
CD4, ITK, and AKT1 were hypermethylated in naïve
CD4+ T cells, with concomitant decreases in transcript
and protein levels. Protein tyrosine phosphatase, recep-
tor type, C (PTPRC, also known as CD45) and KRAS
were two notable exceptions to this pattern. High pro-
tein levels of KRAS have recently been implicated in
lowering the TCR-activation threshold in T cells [49].
Here, we found hypomethylation of KRAS in memory
cells along with high transcript and protein levels. In
contrast, in naïve cells KRAS is hypermethylated and
has lower transcriptional levels, consistent with a higher
TCR activation threshold. Taken together, observations
from this integrated approach are consistent with what
is known about the TCR pathway, demonstrating the
power of a multi-omics dataset to gain comprehensive
molecular insights.
Integration with other datasets
Lastly, we sought to evaluate our data alongside recently
published studies on naïve and memory CD4+ T cells to
examine the concordance and to explore how our data
could complement available datasets.
To investigate the relationship between methylation and
transcription in naïve and memory CD4+ T cells, Komori
et al. utilized RNA-Seq and targeted bisulfite sequencing
of 2,100 genes. They reported 132 genes with differential
methylation between naïve and memory CD4+ T cells. Of
these 132 genes, 39 exhibited a reduction in methylation
with a concurrent increase in transcript abundance in
naïve versus memory cells. Unfortunately, quantitative
methylation values were available for only 40 of these
genes, thus for our analysis we mapped their ‘increased,
no-change, and decreased’ methylation designations for
the 132 genes into a 1, 0, and −1, respectively, for our
analysis. When comparing methylation levels across the
two studies, we observed a Pearson correlation of 0.42
(Additional file 23: Figure S12A). This correlation was
increased to 0.61 when only the 40 genes where methy-
lation values were available were compared (Additional
file 23: Figure S12B).
Next, we evaluated how well methylation levels corre-
lated with expression of transcripts derived from neigh-
boring genes. For this, we limited our comparison to
resting memory CD4+ T cells and unactivated naïve
CD4+ T cells and selected genes that exhibited an inverse
relationship between methylation and transcription. Al-
though Komori et al. described an inverse relationship be-
tween methylation levels and transcription of these genes;
we did not observe a similar general trend in our data
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Fig. 7 (See legend on next page.)
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(Additional file 23: Figure S12C). To determine if this
was due to global differences in transcript levels be-
tween each study, we compared the RPKM values from
Komori et al. with FPKM values from our study. We de-
rived a Pearson correlation coefficient of 0.58 indicating
transcript levels between each respective experiment were
somewhat consistent (Additional file 23: Figure S12D).
Additional experiments will be required to resolve these
apparent disparities.
A recent publication by Graessel et al. characterized
cell surface proteins of naïve and activated naïve CD4+
T cells in which they employed an enrichment strategy
targeting N-glycosylated surface proteins to identify 173
cell surface proteins by mass spectrometry. This was
complemented with flow cytometry to identify an add-
itional 123 cell surface proteins, for a total of 229 pro-
teins expressed on the surface of naïve and activated
naïve CD4+ T cells. Because of the deep proteomic pro-
filing of naïve CD4+ T cells in our study, we sought to
complement Graessel et al.’s surface atlas. Additionally,
because we performed a comparative analysis of naïve and
resting memory CD4+ T cells, we wanted to determine
which changes may be transient during naïve CD4+ T cell
activation, and which protein changes persist to the rest-
ing memory state.
First, to expand upon Graessel et al.’s surface atlas, we
identified proteins from our study using their bioinformatic
strategy of retaining proteins annotated as ‘membrane’ or
‘secreted’ in the UniProtKB/Swiss-Prot databases. This ana-
lysis identified 1,767 candidate proteins in our dataset. To
make a more conservative estimate, we employed an add-
itional criterion of retaining proteins annotated as mem-
brane or extracellular by GO annotation, resulting in 1,166
proteins. We applied the same filters to Graessel et al.’s
proteomic data, and found 146 proteins meeting these cri-
teria. Between our datasets, there was an overlap of 104
cell surface proteins, with 42 proteins being found only in
Graessel et al. and 1,062 proteins being exclusive to our
data (Additional file 24: Figure S13A). The disparity in
depth is likely due to Graessel et al. adopting a N-
glycoprotein protein enrichment strategy as opposed to the
global, deep fractionation methods employed in our study.
Next, we compared the changes measured by Graessel
et al. following naïve CD4+ T cell activation with αCD3/
αCD28. Graessel et al. reported a cluster of 108 proteins
with increased cell surface expression following 24 h of
activation. In our data, we found the protein expression
of these 108 proteins to be, on average, increased in
resting memory CD4+ T cells (Additional file 24: Figure
S13B). Many of these genes are highly associated with
human T cell differentiation and functions such as pro-
liferation (e.g., CD2 superfamily molecules, TNSFS14,
CD147), energy molecule transport (e.g., GLU3, SLC
genes), cellular adhesion and migration (e.g., CD29,
CD226), and components of antigen processing and
presentation to include CD74 (invariant chain) and
HLA molecules.
Conclusions
Technological advances in the fields of genomics, tran-
scriptomics, and proteomics in the last decade have en-
abled us to carry out broad, unbiased studies surveying
the genome, transcriptome, and proteome. Several stud-
ies in the recent past have shown that, sometimes, a sin-
gle study employing many of these approaches can
rediscover most of what was discovered by decades of
research in addition to providing large volumes of novel
data. This is particularly evident in cancer genome se-
quencing studies where a single study of a given cancer
can reveal most mutations that took years of research ef-
forts by multiple investigators as well as revealing novel
gene mutations. With the rapid pace of technologic de-
velopment, the challenge now is to determine ways to
integrate data from these multi-omics approaches. This
would revolutionize biomedical research and enable us
to explore how a given genotype influences phenotype
through various molecular mediators. In addition, this
would also allow us to employ systems biology ap-
proaches to better understand biological systems in
health and disease. Our study is a small step towards en-
couraging such multi-omics approaches to study bio-
logical systems.
Through analysis of the transcriptome, we measured
the baseline expression levels of transcripts in primary
naive and memory CD4+ T cells in addition to revealing
several novel transcripts. Notably, these transcripts were
shown to be differentially expressed across several pri-
mary immune cell populations through RT-PCR amplifi-
cation of each respective transcript. Small RNA analysis
revealed 629 known miRNAs expressed in naive CD4+
(See figure on previous page.)
Fig. 7 T cell receptor signaling pathway showing downstream mediators regulated by DNA methylation, gene/protein expression and/or protein
phosphorylation. T cell receptor signaling pathway depicting genes with their corresponding promoter methylation status, gene and protein
expression levels and phosphorylation status between naïve and memory T cells. Promoter methylation status, transcriptomic, proteomic and
phosphoproteomic measurements were imported into GeneSpring and overlaid onto the TCR signaling pathway to identify molecular signatures
underlying the transition from naïve CD4+ T cells to memory CD4+ T cells. Different shapes are used to denote promoter methylation, mRNA,
protein and phosphorylation status. Red indicates high in naïve CD4+ T cells, blue indicates high in memory CD4+ T cells and the unchanged are
depicted in white. Different colored arrows are used to depict various modes of regulation of pathway components
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T cells as well as 15 putative novel miRNAs. The prote-
ome was extensively profiled and quantified through
various fractionation strategies including sub-cellular
fractionation. This established a baseline abundance esti-
mate of over 7,000 genes expressed in naive CD4+ T
cells and revealed abundantly expressed proteins with
little known function roles. Using a proteogenomic ana-
lysis we uncovered 11 new coding exons and 2 trans-
lated ORFs in the 5′ UTR of known mRNAs. We also
confirmed the translational start site of 1, 720 proteins
and discovered a number of previously unknown start
sites. Our analysis identified 24 new signal peptide cleav-
age sites, and provided protein coding evidence for 3
pseudogenes. Integrating RNA-Seq with whole genome
sequencing allowed us to explore RNA editing and allele
specific expression patterns in primary human cells. We
found low levels of canonical RNA editing, with most
edits occurring within non-coding regions as well as 103
genes that demonstrate transcription patterns consistent
with allele specific expression.
To probe the mechanisms underlying antigen experi-
ence of naive CD4+ T cells, comparisons of the epige-
nome, transcriptome, proteome, and phosphoproteome
were carried out against resting memory CD4+ T cells.
This revealed methylation sites exhibiting regulatory ten-
dencies within genes involved with an immune response
such as LYN, SGK1, CCR6, and CCL5. Comparative pro-
teomics using iTRAQ and phospho-enrichment revealed
differential expression and phosphorylation levels of key
immune related genes. Furthermore, we found that
many proteins with comparable protein levels displayed
significantly different phosphorylation patterns between
the two cell populations. This indicates the regulatory
potential associated with various phosphorylation sites
and demonstrates the power of targeted proteomics to
profile post-translational modifications.
Lastly, our effort revealed several challenges associated
with integrating multi-omic data. The comparison and
integration across various omics datasets is easier if the
depth of coverage is similar; however, each platform
might have biases or issues with sensitivity that preclude
a uniform depth. In addition, comparing different omics
datasets poses challenges because normalizing outputs
from various technological platforms to provide meaning-
ful comparisons is not always possible. Computational al-
gorithms are an essential part of omic data analysis, with
each generating its own share of false positives as well as
false negatives. Such errors could give rise to artificial
conflicts across datasets. However, we foresee that as tech-
nologies mature and data analysis pipelines and method-
ologies become more robust, these challenges will be
overcome in the future. For developing such methods,
availability of multi-omics datasets from similar or
identical biological background is fundamental. This
will mitigate bias due to biological variation and allow re-
searchers to address inconsistencies in data acquisition as
well as data analysis strategies. In that context, our dataset
should prove useful for informatics researchers developing
multi-omics data analysis pipelines.
Methods
Additional details may be found in Additional file 25.
Cell isolation and sample preparation
Blood samples were obtained for isolation of hematopoietic
cells after obtaining informed consent from a healthy sub-
ject. Samples were anonymized prior to analysis and data
deposition. This study was approved by the Johns Hopkins
University’s Institutional Review Board for use of human
samples. Peripheral blood was collected in sodium heparin
containing vacutainer blood collection tubes and
peripheral blood mononuclear cells (PBMCs) were
enriched by Ficoll gradient. Naïve CD4+ T cells were
isolated using magnetic beads following manufacturer’s
instructions (Miltenyi Biotec #130.094.131) and
assessed using FACS Calibur, with the average purity of
each isolation being ~95 % (Additional file 26: Figure
S14A). Resting memory cells were isolated by enriching
pan resting CD4+ T cells followed by CD45RO deple-
tion of resting memory CD4+ T cells, with the average
purity of each isolation also being >95 % (Additional
file 26: Figure S14B). Isolated cells were washed with
cold PBS in large volumes and stored in −80 °C. Gen-
omic DNA was isolated from cells using the FlexiGene
DNA kit, RNA was isolated from cells using RNeasy
mini kit (QIAGEN) and small RNAs were isolated using
miRNeasy mini kit (QIAGEN).
Sequencing and data processing
Whole genome sequencing was performed by Complete
Genomics (CG). 35 bp paired-end reads were generated
by CG and mapped to human reference genome 19.
Total RNA was purified from naïve CD4+ T cells and a
RNA-Seq library was constructed using Illumina’s Tru-
Seq kit and sequenced on HiScanSQ. Reads were aligned
using Tophat version 2.0.10 and transcripts generated by
Cufflinks using a reference annotation comprised of Illu-
mina’s iGenomes, Mark Gerstein’s Pseudogene annota-
tions (version 61), and NONCODE long non coding
RNA (lncRNA). For miRNA sequencing, small RNAs
were gel excised, amplified, sequenced on a HiSeq2000
as single-end reads. Reads ≥18 bp following adapter
trimming were kept, and contaminant sequences were
removed prior to alignment against miRBase 20 with
miRDeep2.
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DNA methylation analysis
DNA was bisulfite converted and analyzed on Illumina’s
HumanMethylation450 BeadChip Array and normalized
using the methylumi R package. Differential DNA
methylation was quantified by determining the differ-
ence of averaged DNA methylation values between
probes and grouped into genomic regions. RMA was
used for all array gene expression analysis and the differ-
ence in expression was computed using average values
from replicate runs. DMRs closest to genes and before
the nearest TSS were plotted against transcript fold
change. To identify CpG sites which are known to regu-
late gene expression, we used the Spearman correlation
coefficient to evaluate the association between DNA
methylation and mRNA expression in primary tumors
from the Cancer Genome Atlas. From these datasets, we
derived an informer set by identifying genes that showed
an inverse relationship between promoter methylation
and gene expression. We derived DNA methylation and
corresponding gene expression differences between
naïve and memory CD4+ T cells at CpG sites of this
gene subset.
Nuclear preparation
Cells were washed in cold PBS and centrifuged at 150×
g. The cell pellet was resuspended in hypotonic lysis buf-
fer (20 mM HEPES, 10 mM KCl, 2 mM MgCl2, 2 mM
CaCl2, pH7.4, protease inhibitor), ruptured by nitrogen
cavitation by pressurizing at 1,500 psi, and crude nuclei
were collected by centrifugation. The pellet was washed
with nuclear wash buffer (250 mM sucrose in hypotonic
buffer) and nuclei collected by centrifuging at 1,000× g
for 10 min at 4 °C and stored at −80 °C until further use.
Protein fractionation, trypsin digestion, and LC MS/MS
analysis
Whole cell lysates were resolved by SDS-PAGE, gel
bands were cut, and in-gel tryptic digestion was per-
formed overnight. Peptides were extracted from the gel
pieces, dried, and analyzed by LC-MS/MS. Protein frac-
tionation was also carried out on GELFREE 8100
fractionation system according to manufacturer’s proto-
col. Each fraction was then subjected to SDS-PAGE,
followed by in-gel tryptic digestion as described above.
Strong-cation exchange (SCX) as well as basic reversed-
phase liquid chromatography (bRPLC) following in-
solution trypsin digestion of protein lysate and LC MS/
MS analysis were performed as described previously
[50]. For iTRAQ based quantitative proteomics experi-
ments, 75 μg of in-solution digested peptides from both
naïve and memory T cells were labelled according to
manufacturer’s protocol.
MS data processing and database searching
MS data were processed using Proteome Discoverer 1.3
(Thermo Fisher Scientific) and searched using Mascot
version 2.2 and Sequest search algorithms against a hu-
man RefSeq protein sequence database and proteoge-
nomics analysis was conducted as described previously
[51, 52]. Identified peptides were subjected to a 1 % false
discovery rate (FDR) filter using the decoy database
method.
Phosphopeptide enrichment and label-free quantitation
Lysates from naïve and memory CD4+ T cells were
digested using in-solution trypsin digestion and phospho-
peptides were enriched using TiO2-based enrichment
protocol. Phosphopeptides were desalted by Stage-Tip and
subjected to LC-MS/MS using Triple-TOF mass spec-
trometer with a long gradient. Spectra were searched
against human protein database using Mascot and Pro-
teinPilot and peptides were identified by setting a thresh-
old of 1 % FDR. Phosphopeptide abundance was
quantitated by label-free method using MassNavigator.
AreaScore(L) was used to assess the confidence of the area
quantitation and areas were normalized based on a total
summed intensity of proteomic analysis.
Data availability
Mass spectrometry derived proteomics data has been de-
posited to the ProteomeXchange Consortium (http://pro-
teomecentral.proteomexchange.org) via the PRIDE partner
repository with the dataset identifier PXD000376. All
sequencing data has been deposited to the Short Read
Archive under the BioProject identifier PRJNA234019.
Additional files
Additional file 1: Figure S1. Data generated on naïve CD4+ T cells and
memory CD4+ T cells. Basic metrics assaying the quality of generated
data are provided for each dataset generated. (PDF 60 kb)
Additional file 2: Figure S2. Sequence variants identified in the
genome and classification of SNPs in protein coding regions. (A) Total
number of SNPs, insertions, deletions and substitutions identified from
whole genome sequencing data. (B) Proportion of synonymous and
non-synonymous SNPs identified in the coding region of the genome
among non-synonymous SNPs (nsSNPs), proportion of conservative and
non-conservative homozygous and heterozygous changes are shown. (C)
nsSNP frequency across various molecular classes of genes. (PDF 68 kb)
Additional file 3: Figure S3. Distribution of assembled transcripts
based on abundance (FPKM) and corresponding read density. The x-axis
represents abundance threshold (FPKM) and y-axis represents read
density. The red and green lines represent the Gaussian Mixture Model
that was applied to assembled transcripts. The abundance threshold
(represented by vertical dotted line) separates transcripts identified as
true positives on the right (supported by more reads) from those identified
as potential false positives on the left (supported by less reads). The two
screenshots taken from genome browser demonstrates examples of high
read density and low read density. (PDF 226 kb)
Additional file 4: Table S1. A list of genes expressed in naïve CD4+ T
cells. (XLSX 403 kb)
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Additional file 5: Table S2. A list of novel transcripts and novel spliced
isoforms identified in naïve CD4+ T cells. (XLSX 9927 kb)
Additional file 6: Table S3. A list of known and novel miRNAs
identified in naïve CD4+ T cells. (XLSX 22 kb)
Additional file 7: Figure S4. Example of a miRNA identified and the
distribution of reads across a predicted hairpin structure. Putative novel
miRNA identified from small RNA-Seq. Predicted stem loop structure,
mature region and star regions are shown. (PDF 50 kb)
Additional file 8: Table S4. A list of proteins identified in naïve CD4+ T
cells. (XLSX 634 kb)
Additional file 9: Table S5. A list of uncharacterized proteins
annotated as open reading frames in public databases that were
identified in naïve CD4+ T cells. (XLSX 16 kb)
Additional file 10: Table S6. A list of genes displaying allele specific
expression. (XLSX 15 kb)
Additional file 11: Figure S5. Strategy employed for determining
potential RNA editing sites . The workflow that was followed to filter out
false positive RNA-editing sites is shown. Examples of false positives
due to mismapping of reads and uncalled SNPs is demonstrated with
sequence alignment. Abbreviations (SNP: single nucleotide polymorphism;
RDD: RNA-DNA difference; CNV: copy number variation). (PDF 65 kb)
Additional file 12: Figure S6. Proteogenomic pipeline. Custom protein
databases that were used for searching tandem mass spectrometry data
for proteogenomic annotation. (PDF 59 kb)
Additional file 13: Table S7. A list of peptides supporting novel exons
or exon extensions identified using proteogenomics strategy. (XLSX 9 kb)
Additional file 14: Table S8. A list of known and novel signal peptide
cleavage sites identified for membrane/secreted proteins expressed in
naïve CD4+ T cells. (XLSX 11 kb)
Additional file 15:Table S9. A list of annotated pseudogenes that
encode proteins in naïve CD4+ T cells with the corresponding peptide
evidence from proteomics data. (XLSX 9 kb)
Additional file 16: Figure S7. Comparison of a protein’s abundance
versus its transcriptional abundance. Scatterplot of protein abundance
versus transcript abundance is shown. Transcript abundance is
represented as FPKM (log2) on the x-axis and protein abundance is
represented as normalized iBAQ (log2) on the y-axis. (PDF 487 kb)
Additional file 17: Figure S8. Correlation between miRNA read count,
transcript, and protein abundance. (A) Protein abundance versus miRNA
read count. The x axis for each circle represents all miRNAs identified
with a given read count while the y axis corresponds to the average
iBAQ value of the genes targeted by those miRNAs with the specified
read count. The dashed red line represents the iBAQ value of genes that
are not targeted by any miRNAs identified in this study and serves as a
background, reference level of protein expression. The black line is a
linear regression of iBAQ values versus the miRNA read count. (B)
Transcript abundance versus miRNA read count. The x axis for each circle
represents all miRNAs identified with a given read count while the y axis
corresponds to the average FPKM value of the genes targeted by those
miRNAs with the specified read count. The dashed red line represents
the FPKM levels of genes that are not targeted by any miRNAs identified
in this study and serves as a background, reference level of transcript
abundance. The black line is a linear regression of FPKM values versus
miRNA read count. There is no obvious correlation between FPKM values
and miRNA read counts. (PDF 150 kb)
Additional file 18: Figure S9. DNA methylation pattern across various
gene features on all protein coding genes in naïve CD4+ T cells. The x-
axis represents various gene features in protein coding genes (TSS1500 -
1,500 bp upstream of transcription start site, TSS200 - 200 bp upstream of
transcription start site, 5′ UTR – 5′ untranslated region, 1st exon, gene
body and 3′ UTR – 3′ untranslated region) and the y-axis represents beta
value which is an estimate of methylation level. Box-Whisker plots show
median methylation levels at each gene feature across all protein coding
genes in naïve CD4+ T cells. (PDF 1313 kb)
Additional file 19: Figure S10. Correlation of methylation level at
different gene features with transcript and protein expression levels. (A)
Promoter methylation level and corresponding transcript abundance
Methylation levels are represented by Beta values and transcript
abundance is represented by FPKM values. (B) Scatterplots showing
methylation levels at different gene features and transcript abundance.
Methylation levels are represented on the x-axis and transcript abundance is
represented on the y-axis. The red dot represents the mean methylation
levels and transcript abundances. Spearman’s correlation coefficent is
represented below each scatterplot. (C) Promoter methylation level and
corresponding protein abundance (iBAQ values from Fig. 4). (D) Scatterplots
showing methylation levels at different gene features and protein
abundance. Methylation levels are represented on the x-axis and
protein abundance is represented on the y-axis. The red dot represents
the mean methylation levels and protein abundances. Spearman’s
correlation coefficent is represented below each scatterplot.
(PDF 1087 kb)
Additional file 20: Figure S11. Correlation of methylation and
transcript levels of genes between memory and naïve CD4+ T cells. (A)
Intersection of promoter methylation and mRNA expression data from
naïve and memory T cells. Genes marked in red in the upper left
quadrant showed significantly reduced expression in naïve CD4+ T cells
due to promoter hypermethylation. Genes that showed the opposite
trend are shown in the bottom right quadrant. (PDF 185 kb)
Additional file 21: Table S10. A list of regulatory methylation sites
derived from TCGA data. (XLSX 418 kb)
Additional file 22: Table S11. Pathways enriched from Gene Set
Analysis of genes correlating with TCGA dataset 1 or dataset 2.
(XLSX 12 kb)
Additional file 23: Figure S12. Concordance of this study with Komori
et al. (A) Each blue dot represents the methylation level of a gene. On
the x-axis are the methylation differences between memory and naïve
cells measured by Komori et al. and on the y-axis are TSS200 methylation
levels measured in this study. The r2 value is a pearson’s correlation
coefficient between the two datasets. (B) Each blue dot represents the
methylation level of a gene. On the x-axis are the methylation differences
between memory and naïve cells where Komori et al. provided quantitative
values and on the y-axis are the TSS200 methylation levels measured in this
study. The r2 value is a pearson’s correlation coefficient between the two
datasets. (C) Genes identified in Komori et al. as displaying inverse correlation
between methylation levels and transcription are plotted. On the left axis
and shown in blue are the log2 transformed fold change of transcript levels
between memory and naïve cells measured by Komori et al. and on the
right axis and shown in green are log2 transformed fold change of transcript
levels between memory and naïve cells measured in this study. (D) The
correlation between the log2 transformed fold changes of genes between
memory and naïve cells measured in each study is shown. Each blue dot
represents a gene and the r2 is a pearson’s correlation coefficient.
(PDF 1410 kb)
Additional file 24: Figure S13. Cell surface proteins of naïve CD4+ T
cells and their expression compared to resting memory CD4+ T cells (A)
Cell surface proteins found in this study are compared against those
found by Graessel et al. (B) iTRAQ measurements within this study are
shown for cell surface proteins that Graessel et al. found to be increased
in activated naïve CD4+ T cells. (PDF 75 kb)
Additional file 25. Supplemental methods. (DOC 41 kb)
Additional file 26: Figure S14. Purity of naïve CD4+ T cells and
memory CD4+ T cells. (A) FACS-plot showing the purity of naïve CD4+ T
cells. (B) FACS-plot showing the purity levels of memory CD4+ T cells.
(PDF 71 kb)
Abbreviations
FPKM: Fragments per kilobase of exon per million fragments mapped;
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PBMCs: Peripheral blood mononuclear cells; CG: Complete genomics;
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